Update: ChromaDex will demonstrate how it’s raising the bar on ingredient technology, applications innovation and raw mate...
September 15 2016 - 4:57PM
ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health,
wellness and nutritional ingredients that creates science-based
solutions for dietary supplement, food and beverage, skin care,
sports nutrition, and pharmaceutical products, announced today that
it will showcase a number of industry-advancing health and wellness
products and services during this year’s SupplySide West, October 4
through 8 in Las Vegas. Attendees stopping by booth
#P137 will see live demonstrations and explore
exciting new ingredients, including the new AnthOrigin™,
naturally-extracted anthocyanins.
Three reasons to spend time at the ChromaDex
booth:
- See a live demonstration of NEW AnthOrigin™ power caps
into water. This powerful antioxidant from domestically
grown, water-extracted, non-GMO purple corn husk extract contains a
minimum of 15 percent anthyocyanins.
- Newly published NIAGEN® research and power cap
demonstration. University of Pennsylvania researchers have
uncovered an important clue as to why our muscles weaken as we age,
and how NR (nicotinamide riboside)– when combined with exercise and
a healthy diet – might help us to maintain or even regain some of
that muscle strength.
- Special pricing on phytochemical reference standards
orders. ChromaDex experts will be on hand to discuss the
company’s industry-leading reference standards library and their
new online ordering capabilities. Be sure to ask for your 15% off
coupon, valid for all online phytochemical reference standards
orders placed October 6 through October 14, for shipment in
October. Try out this time saver today.
About ChromaDex: ChromaDex leverages its
complementary business units to discover, acquire, develop and
commercialize patented and proprietary ingredient technologies that
address the dietary supplement, food, beverage, skin care and
pharmaceutical markets. In addition to our ingredient technologies
unit, we also have business units focused on natural product fine
chemicals (known as "phytochemicals"), chemistry and analytical
testing services, and product regulatory and safety consulting
(known as Spherix Consulting). As a result of our relationships
with leading universities and research institutions, we are able to
discover and license early stage, IP-backed ingredient
technologies. We then utilize our in-house chemistry, regulatory
and safety consulting business units to develop commercially viable
ingredients. Our ingredient portfolio is backed with clinical and
scientific research, as well as extensive IP protection. Our
portfolio of patented ingredient technologies includes NIAGEN®
nicotinamide riboside; pTeroPure® pterostilbene; PURENERGY®, a
caffeine-pTeroPure® co-crystal; IMMULINA™, a spirulina extract; and
AnthOrigin™, anthocyanins derived from a domestically-produced,
water-extracted purple corn. To learn more about ChromaDex, please
visit www.ChromaDex.com.
Forward-Looking Statements:
This release contains forward-looking statements
within the meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities and
Exchange Act of 1934, as amended, including statements related to
results of the NIAGEN® studies and their significance. Statements
that are not a description of historical facts constitute
forward-looking statements and may often, but not always, be
identified by the use of such words as "expects", "anticipates",
"intends", "estimates", "plans", "potential", "possible",
"probable", "believes", "seeks", "may", "will", "should", "could"
or the negative of such terms or other similar expressions. More
detailed information about ChromaDex and the risk factors that may
affect the realization of forward-looking statements is set forth
in ChromaDex's Annual Report on Form 10-K for the fiscal year ended
January 2, 2016, ChromaDex's Quarterly Reports on Form 10-Q and
other filings submitted by ChromaDex to the SEC, copies of which
may be obtained from the SEC's website at www.sec.gov. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof, and actual
results may differ materially from those suggested by these
forward-looking statements. All forward-looking statements are
qualified in their entirety by this cautionary statement and
ChromaDex undertakes no obligation to revise or update this release
to reflect events or circumstances after the date hereof.
ChromaDex Public Relations Contact:
Breah Ostendorf, Director of Marketing
949-537-4103
breaho@chromadex.com
ChromaDex Investor Relations Contact:
Andrew Johnson, Director of Investor Relations
949-419-0288
andrewj@chromadex.com
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Aug 2024 to Sep 2024
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Sep 2023 to Sep 2024